Search
Careers
Call Us Now: +1 (737) 787-4313
Menu
Controlled Substance Experts
Unified Services
API Process Development
Analytical Development
Formulation Development
Manufacturing Services
Regulatory Services
Commercial Services
Specialized Solutions
Discovery Booster
Clinical Expressway
Market Accelerator
Stability Solutions
Our Company
Company News
Company Events
Careers
Knowledge Center
Case Studies
Whitepapers
Our Company
Latest News &
Press Releases
Check out all of the most recent goings-on here at Benuvia.
Benuvia Receives Second NIH Award to Advance GMP-Grade Ketanserin Development for Psychedelic Research
Read More
Benuvia Partners with TIRC to Manufacture Pharmaceutical-Grade Ibogaine API
Read More
Benuvia Files Psilocybin DMF Number 040053
Read More
Benuvia and Mikart Announce Strategic Co-Marketing Partnership
Read More
Benuvia Operations Supports FDA IND Filing by Mandara Biopharma for Dronabinol Oral Solution in Alzheimer’s Agitation
Read More
Khona Scientific and Benuvia Operations Sign Letter of Intent to Advance Biosynthetic Development of Controlled-Substance APIs
Read More
Benuvia Operations Announces Strategic Partnership with Cannovation Clinical Research Partners to Deliver Fully Integrated Solutions for Controlled-Substance Therapeutics
Read More
Benuvia Operations Signs Research and Manufacturing Agreement with Leading Ivy League Research University
Read More
Benuvia Sees a Turning Point for Cannabinoid Medicine as Public Awareness Grows
Read More
Advancing Ibogaine Development? You May Be Overlooking a $50M Opportunity
Read More
Shifting Supply Chains Prompt Growing Demand for U.S.-Based CDMO Solutions
Read More
Benuvia Operations Signs Commercial Supply Agreement with Leading U.S. Pharmaceutical Company for Dronabinol API
Read More
1
2
Next »
